PivotMark Cuban on Running for President as a Republican: "It Would Be SO Much Fun" | Pivot
CHAPTERS
- 0:00 – 2:19
TrumpRX partnership: referral traffic, higher volume, and lower Cost Plus prices
Kara and Mark open by discussing the TrumpRX portal and why Cost Plus Drugs participates: it routes consumers to the cheapest option and boosts volume. Cuban argues higher volume reduces his costs, and because his model is “cost + 15%,” those savings flow to customers.
- •TrumpRX functions as a price-lookup portal that can refer users to Cost Plus
- •Cuban frames the partnership as apolitical: everyone wants cheaper drugs
- •Increased volume can reduce unit costs; Cost Plus passes savings through
- •Cuban claims prices dropped on 200+ medications since the portal launched
- 2:19 – 8:21
What’s actually driving RX price declines: IRA negotiation, Medicare caps, and biosimilars
Cuban breaks down multiple reasons drug prices may be falling, separating the Inflation Reduction Act’s Medicare negotiation and out-of-pocket caps from broader market forces. He emphasizes biosimilars as the biggest driver of dramatic price drops for high-cost injectables.
- •IRA negotiation for a limited set of drugs helps and Medicare caps reduce patient exposure
- •Premiums can rise when insurers absorb changes from Medicare caps
- •Biosimilars are “generics for injectables,” enabling steep declines
- •Examples: Stelara and Humira price drops via biosimilar competition
- 8:21 – 11:06
Broken healthcare economics: conglomerates, PBMs, opacity, and administrative burnout
The conversation widens from drugs to the whole healthcare system, which Cuban argues is dominated by a few vertically integrated conglomerates. He stresses that complexity and lack of price transparency are features, not bugs, creating leverage for middlemen and contributing to doctor burnout.
- •United/Cigna/CVS-style conglomerates own layers of middlemen and providers
- •Information asymmetry enables price discrimination and hidden fees
- •Administrative friction reduces doctor-patient time and fuels burnout
- •Cost Plus positions itself as a transparency counter-model
- 11:06 – 13:50
How PBMs maintain control: formularies, rebate leverage, and blocking Cost Plus from brands
Cuban explains the PBM playbook: using formulary control to force manufacturers into rebate arrangements and to punish those who work with disruptors. He describes why brand and specialty manufacturers won’t sell through Cost Plus despite demand.
- •PBMs’ formulary control creates coercive leverage over drugmakers’ portfolios
- •Manufacturers fear losing preferred status across many products
- •PBM contracts are highly secretive (“Fight Club” rules)
- •Cuban says transparency destabilizes PBM/insurer pricing power
- 13:50 – 15:52
Why transparency is so hard: TRICARE example and political barriers to reform
Cuban highlights how even government stakeholders struggle to extract pricing data from PBMs, citing TRICARE and Elizabeth Warren’s requests. He then points to stalled legislative momentum, even for bipartisan ideas like Hawley/Warren’s breakup proposal, blaming money in politics.
- •Express Scripts/TRICARE cited as refusing to disclose pricing to policymakers
- •Secrecy is systemic, not incidental, across pharmacy pricing
- •Cuban backs “Break Up Big Medicine” but notes no co-sponsors
- •He claims senators privately admit dependence on industry money
- 15:52 – 17:52
Costco enters Medicare: branding vs structural change in Medicare Advantage
Kara asks whether Costco-branded Medicare plans signal a better future for healthcare. Cuban argues it’s mainly sales/marketing: incremental perks may improve value, but the underlying math and private-insurer incentives remain unchanged.
- •Medicare Advantage is predominantly private insurance
- •Costco may add trusted branding and incremental benefits (OTC, vision, hearing)
- •Traditional Medicare still requires supplemental coverage and Part D complexity
- •Cuban says real reform requires removing middlemen, not new brand wrappers
- 17:52 – 22:44
Using AI to find hidden fees: ‘run the contract through Claude/ChatGPT’
Cuban pitches a practical tactic: employers and governments should analyze health-benefit contracts with LLMs to uncover mismatched definitions and buried exclusions. He argues healthcare savings can directly fund other priorities (including AI spend) and that fear of employee disruption blocks change.
- •LLMs can quickly identify contradictions, carve-outs, and fee games in long contracts
- •PBMs exploit definitions (e.g., “pass-through” that excludes specialty drugs/fees)
- •Self-insured employers can save millions, but resist switching insurers/logos
- •Healthcare savings become immediate bottom-line cash flow for companies
- 22:44 – 25:10
Divestment campaign against big insurers: moral pressure vs index reality
Kara asks about Cuban’s call for investors to push funds to divest from major insurers. Cuban is skeptical it will work at scale, especially for index funds, but argues behavior changes only when stock prices or capital access are threatened.
- •Index inclusion limits divestment flexibility for many funds
- •Earnings calls rarely prioritize lowering patient costs, Cuban claims
- •He argues only stock-price pressure forces insurer/PBM change
- •Activist energy is misallocated if it ignores insurer incentive structures
- 25:10 – 32:19
‘Chips are the new crypto’: tokenizing compute and renting GPUs like real estate
Cuban pivots to his prediction that AI chips could become a tradeable asset class with a hype narrative similar to crypto. He explains why he reduced Bitcoin exposure, critiques crypto’s narrative drift, and proposes financial structures to tokenize chip revenue streams.
- •Cuban says Bitcoin ‘lost the plot’ as a hedge despite macro instability
- •Chips can be monetized via rental/lease economics; value decays over time
- •Tokenization could represent ownership/rights to chip output or revenues
- •He’s disappointed smart-contract utility didn’t reshape apps as hoped
- 32:19 – 43:14
Why billionaires buy teams: vanity, real estate leverage, and media-rights risk
After the break, Kara and Cuban discuss soaring sports-team valuations amid private equity involvement. Cuban frames teams as vanity assets with real money made through surrounding development, arenas/events, and media rights—while warning valuations depend on streaming economics and broader asset prices.
- •Teams increase personal profile and cultural relevance (vanity asset)
- •Profits often come from arenas, concerts, and adjacent real estate
- •Media-rights deals are a major valuation driver; streaming churn is the fulcrum
- •Leverage/financial engineering can break if asset prices fall or loans get called
- 43:14 – 50:24
California’s proposed billionaire tax: liquidity, non-recourse loans, and job-loss math
Cuban criticizes the proposed one-time billionaire tax structure, especially the idea of the state lending against illiquid shares so founders can pay the tax. He argues it could backfire by accelerating out-migration and reducing employment, while acknowledging appetite for higher taxes on the wealthy.
- •Billionaire status often reflects illiquid stock, not cash
- •State-backed loans against private shares create weird incentives and risks
- •Projected revenue could be offset by lost jobs and economic contraction
- •Cuban prefers alternatives like AMT concepts and structural fixes over headline taxes
- 50:24 – 54:17
Turning against Big Tech: Meta scams, AI-driven ‘ends justify the means,’ and trust collapse
Kara and Cuban connect public anger over taxes and data centers to distrust of tech platforms. Cuban cites AI-generated scam ads impersonating him on Facebook as emblematic of a culture that tolerates fraud, driven by pressure to fund expensive AI infrastructure.
- •Cuban says Meta allows AI impersonation scams targeting vulnerable users
- •He argues data-center/AI costs push platforms toward more aggressive monetization games
- •He compares Big Tech’s opacity and extraction to healthcare middlemen tactics
- •Kara notes broader content piracy issues (e.g., AI audiobook uploads)
- 54:17 – 59:30
Medicare for All skepticism: unrealistic savings assumptions and ‘plan vs slogans’
Cuban critiques Medicare for All studies and legislation for what he sees as dubious assumptions—especially around fraud elimination and administrative savings. He argues universal coverage needs a credible transition plan, not optimistic extrapolations or vague delegation to political appointees.
- •He disputes large ‘fraud elimination’ savings figures as unrealistic
- •Administrative-savings claims ignore hospital cost structures and doctor opt-outs
- •Warns about broad discretion concentrated in HHS leadership
- •Agrees universal coverage is needed, but insists on honest, executable steps
- 59:30 – 1:06:29
Will Mark Cuban run for president? Why he says no—and why a GOP/independent run tempts him
Kara presses Cuban on presidential ambitions; he says governance is constrained by laws, incentives, and political reality, while entrepreneurship lets him create direct impact. He jokes that running as a Republican would be ‘so much fun,’ and says an independent run would be the most viable path.
- •Cuban argues he’s more effective changing systems as an operator than a politician
- •He cites lack of Senate support for healthcare reform as a hard constraint
- •Says he lacks the temperament/patience for the job’s required diplomacy
- •Entertains the idea of running as a Republican or independent; notes rise of independents
- 1:06:29 – 1:09:59
Predictions: James Talarico’s prospects and the Meta ‘hook/hold/harvest/hide’ case
In closing predictions, Cuban endorses James Talarico as an honest candidate with crossover appeal, while Kara predicts the Meta case marks the beginning of a broader accountability wave akin to tobacco litigation. Both emphasize algorithmic control as central to politics and youth well-being.
- •Cuban praises Talarico’s authenticity and outreach in red areas
- •He frames voter persuasion around tangible outcomes (‘what have they done for you?’)
- •Kara spotlights states’ case against Meta: hook, hold, harvest, hide
- •Both argue algorithm control shapes minds and political realities
